Agenda Revolutionizing Transplantation 2024

6:30 a.m.                 

Registration, Breakfast & View Exhibits

7 a.m.

Non-CME Breakfast Symposium Hosted by Eurofins Viracor

CMV T Cell Immunity and TTV Viral Load Monitoring—Innovative Tools for Improved Patient Management

Steve Kleiboeker, MD

7:55 a.m.                           

Welcome and Introductions

8 a.m.

Advancing Transplantation Outcomes with Genomics and Biomarker Discovery

Alexander Wiseman, MD

8:30 a.m.

Urinary Exosome mRNA as a Diagnostic Signature for Kidney Transplant Rejection              

Jamil Azzi, MD

9 a.m.

The Clinical Promise of Novel Noninvasive Biomarkers in Liver Transplantation

TBC

9:30 a.m.           

Panel Discussion/Q&A

9:45 a.m.                           

Break & View Exhibits

10:15 a.m.

The Role of T Cell Responses in the Interplay of Transplantation and Immunosuppression 

Mandy Ford, MD

10:45 a.m. 

Advancing Heart Transplant Care: Innovations in Non-Invasive Diagnostic Approaches for Post-Transplant Monitoring

Kiran Kaur Khush, MD

11:15 a.m.

Pioneering Graft Success: The Role of Translational Microbiome Research in Transplantation

John Lee, MD

11:45 a.m.                       

Panel Discussion/Q&A

Noon

Non-CME Lunch Symposium Hosted by Natera

Prospera: The cf-DNA Biomarker Transforming Kidney Transplant Monitoring

Hossein (Hoss) Tabriziani, MD

1 p.m.

Organoid Technology in Graft Regeneration, Disease Modeling, and Tissue Engineering

Jorke Willemse, PhD

1:30 p.m.

Genomic Insights to Therapeutic Avenues in CKD and Transplant Fibrosis

Madhav Menon, MD

2 p.m.

Decoding the Indicators of Transplant Rejection: Pre-transplant Donor Reactive CD8+ T Cell Clones

James Mathew, MD

2:30 p.m.

Panel Discussion/Q&A

2:45 p.m.          

Break & View Exhibits

3 p.m.

A Transplant Recipient's View on the Evolution of Post-Transplant Molecular Monitoring

Stanley Rose, PhD

3:30 p.m.

Unraveling Gender Disparities: Understanding Sex Differences in Transplantation Outcomes

Dianne McKay, MD

4 p.m.

Customizing Immunosuppression for Liver Transplants: A Personalized Medicine Approach

Ali Zarrinpar, MD

4:30 p.m.

Panel Discussion/Q&A

4:45 p.m.          

Adjourn

**Topics, times, and order of talks subject to change